Tilray Brands (TLRY) Cash from Operations Growth (1y) (2018 - 2026)
Tilray Brands (TLRY) Cash from Operations Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.06 Bn | 87.19 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 61.90% |
| 3 | Zoetis | 32.39 Bn | 30.45 Bn | 1.62 Bn | -22.14% |
| 4 | Takeda Pharmaceutical | 27.59 Bn | 23.53 Bn | 4.39 Bn | 8.20% |
| 5 | United Therapeutics | 23.19 Bn | 21.04 Bn | 648.10 Mn | 0.46% |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - | - |
| 7 | Viatris | 20.27 Bn | 18.46 Bn | 1.16 Bn | -27.49% |
| 8 | Neurocrine Biosciences | 18.00 Bn | 16.69 Bn | 800.70 Mn | 125.00% |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn | 425.00% |
| 10 | Tilray Brands | 447.32 Mn | 387.13 Mn | 54.95 Mn | -280.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -280.87% |
| Nov 30, 2025 | 79.04% |
| Aug 31, 2025 | 96.20% |
| May 31, 2025 | -141.71% |
| Feb 28, 2025 | 62.50% |
| Nov 30, 2024 | -33.92% |
| Aug 31, 2024 | -122.87% |
| May 31, 2024 | -29.57% |
| Feb 29, 2024 | 17.56% |
| Nov 30, 2023 | -204.11% |
| Aug 31, 2023 | 65.76% |
| May 31, 2023 | 312.42% |
| Feb 28, 2023 | 59.84% |
| Nov 30, 2022 | 270.60% |
| Aug 31, 2022 | 50.37% |
| May 31, 2022 | -348.81% |
| Nov 30, 2021 | -802.26% |
| Aug 31, 2021 | -66.18% |
| May 31, 2021 | -87.62% |
| May 31, 2020 | 526.86% |